title: Impact of axial spondyloarthritis clinical features on cardiovascular risk
abstract: Axial spondyloarthritis (axSpA) is a group of inflammatory disorders characterized by the involvement of axial and peripheral joints, as well as systemic manifestations. Cardiovascular diseases (CVD) are a leading cause of mortality in patients with axSpA, and anti-inflammatory therapy with NSAIDs may further increase cardiovascular risk (CVR). While conventional CVR factors are well-established, a comprehensive CVR assessment in axSpA requires consideration of disease-specific features that com
journal: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice